Senior insider sale
President & CEO at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$190.5K
11.75K shares
What this filing means
BRYNJELSEN SEAN plans to sell 11.75K shares of ETON PHARMACEUTICALS, INC. valued at approximately $190.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/14/2026ACC: 0001974078-26-000013
DirectorOfficer· President & CEO
Since Nov 2018
11.75K
Shares to sell
$190.5K
Approx. market value
180K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
GRANT
CASH
1/13/2026
180KTotal acquired180K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/13/2026 | GRANT CASH | 180K | — |
| Total | 180K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
6.73K
Market value
$113.3K
12/12/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.01K
Market value
$77.2K
1/14/2026
Total
Units
11.75K
Value
$190.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/12/2025 | 6.73K | $113.3K | — | Completed |
| Planned — Approximate Date | ||||
1/14/2026 | 5.01K | $77.2K | NASDAQ | Planned |
| Total | 11.75K | $190.5K | ||